Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole dosing methods for ovarian stimulation before IUI
IRCT20220412054511N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of letrozole in female infertility (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Number of follicles on cycle days 9 to 11, Diameter of the largest follicle and 4 more. Started Feb 2023; status: completed.
02
Drugs
letrozole
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20220412054511N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220412054511N1.